Skip to main content

Table 1 Characteristics of the subjects in both groups at initial visit (before taking drugs)

From: LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand

Parameters mean ± standard deviation (90 % confidence interval) P-value
  1st group (N = 22) 2nd group (N = 21)  
Age (years) 48.90 ± 10.83 48.45 ± 9.36 NS
  (45.01–52.79) (45.17–51.73)  
Total cholesterol (mg/dL) 259.30 ± 31.83 254.40 ± 33.47 NS
  (247.87–270.73) (242.66–266.14)  
HDL (mg/dL) 45.50 ± 12.27 44.80 ± 10.04 NS
  (41.10–49.90) (41.28–43.32)  
Triglyceride (mg/dL) 160.00 ± 90.71 168.40 ± 89.23 NS
  (127.44–192.56) (137.11–199.69)  
LDL (mg/dL) 181.90 ± 25.33 175.90 ± 30.71 NS
  (172.81–190.99) (165.13–186.67)  
Sgot (U/L) 26.40 ± 10.33 24.50 ± 8.38 NS
  (22.69–30.11) (21.56–27.44)  
Sgpt (U/L) 30.00 ± 15.26 31.30 ± 20.95 NS
  (24.52–35.48) (23.95–38.65)  
CPK (U/L) 123.80 ± 68.94 125.70 ± 73.54 NS
  (99.05–148.55) (99.91–151.49)